Form 4 for AYTU AYTU BIOPHARMA, INC
Accepted 2024-11-13 00:00:00 ET · period of report 2024-11-11 · accession 0000912282-24-000798 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-13 | 2024-11-11 | AYTU | Selhorn Ryan J | CFO | A - Grant | $0.00 | +14.0K | 15.9K | +739% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-11-11 | A | A | 14,000 | $0.00 | 15,895 | D | — | — | (F1) Represents shares of restricted stock which vest as follows: One-third on November 11, 2025; 1/12th of the original grant quarterly thereafter through November 11, 2027. |